OraSure Technologies Appoints New Senior Vice President, Business Development
11 April 2018 - 6:05AM
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care
diagnostic tests and specimen collection devices, today announced
that David Rappaport has been appointed as the Company’s new Senior
Vice President, Business Development.
Prior to joining OraSure, Mr. Rappaport served
as Senior Vice President, Healthcare Investment Banking at Raymond
James & Associates where he provided investment banking
services in the Life Sciences practice group. Prior to his
tenure at Raymond James, Mr. Rappaport served as a healthcare
investment banker with Inverness Advisors, Thomas Weisel Partners
and SG Cowen. Mr. Rappaport received a Bachelors of Business
Administration in Finance and Economics from the University of
Wisconsin - Madison and an MBA from Emory University.
“We are pleased that David will be heading up
our business development function,” said Stephen S. Tang, Ph.D.,
President and CEO of OraSure Technologies. “The
identification, evaluation and acquisition of new products,
businesses and technologies will be a key priority as we continue
to build our business. David’s strong investment banking
experience in the life sciences field is an ideal background for
him to lead our M&A activities and contribute to the
development and execution of our strategic business plans. I
look forward to working with David as we execute against our
strategic priorities.”
About OraSure
Technologies
OraSure Technologies is a leader in the
development, manufacture and distribution of point of care
diagnostic and collection devices and other technologies designed
to detect or diagnose critical medical conditions. Its
first-to-market, innovative products include rapid tests for the
detection of antibodies to HIV and HCV on the OraQuick® platform,
oral fluid sample collection, stabilization and preparation
products for molecular diagnostic applications, and oral fluid
laboratory tests for detecting various drugs of abuse. OraSure's
portfolio of products is sold globally to various clinical
laboratories, hospitals, clinics, community-based organizations and
other public health organizations, research and academic
institutions, distributors, government agencies, physicians'
offices, commercial and industrial entities and consumers. The
Company's products enable healthcare providers to deliver critical
information to patients, empowering them to make decisions to
improve and protect their health. For more information on OraSure
Technologies, please visit www.orasure.com.
Company contact:
Shauna White |
Corporate Marketing
Manager |
484-353-1575 |
media@orasure.com |
www.orasure.com |
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024